|
1
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gish RG and Baron A: Hepatocellular
carcinoma (HCC): Current and evolving therapies. IDrugs.
11:198–203. 2008.PubMed/NCBI
|
|
3
|
Bruix J, Sala M and Llovet JM:
Chemoembolization for hepatocellular carcinoma. Gastroenterology.
127:179–188. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gacche RN: Compensatory angiogenesis and
tumor refractoriness. Oncogenesis. 4:e1532015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Onco. l29(6 Suppl 16): S15–S18. 2002.
View Article : Google Scholar
|
|
6
|
Zhang C, Li K and Wang J: The effect of
rh-endostatin on micrangium and angiogenic factors in tumor and
myocardium tissue. Chin German J Clin Oncol. 11:43–48. 2012.
View Article : Google Scholar
|
|
7
|
Yan JC, Ding S, Liang Y, Liu PJ, Ren GQ,
Zhu J, Ma GS, et al: Effect of CD_(40)-CD_(40) ligand interaction
on proliferation and migration in cultured human umbilical vein
endothelial cells. China J Modern Med. 2496–2499. 2007.(In
Chinese).
|
|
8
|
Murphy JF, Lennon F, Steele C, Kelleher D,
Fitzgerald D and Long AC: Engagement of CD44 modulates
cyclooxygenase induction, VEGF generation, and cell proliferation
in human vascular endothelial cells. FASEB J. 19:446–448. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ao JY, Chai ZT, Zhang YY, Zhu XD, Kong LQ,
Zhang N, Ye BG, Cai H, Gao DM and Sun HC: Robo1 promotes
angiogenesis in hepatocellular carcinoma through the Rho family of
guanosine triphosphatases' signaling pathway. Tumour Biol.
36:8413–8424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ling Y, Yang Y, Lu N, You QD, Wang S, Gao
Y, Chen Y and Guo QL: Endostar, a novel recombinant human
endostatin, exerts antiangiogenic effect via blocking VEGF-induced
tyrosine phosphorylation of KDR/Flk-1 of endothelial cells. Biochem
Biophys Res Commun. 361:79–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang S, Lu XA, Liu P, Fu Y, Jia L, Zhan S
and Luo Y: Endostatin has ATPase activity, which mediates its
antiangiogenic and antitumor activities. Mol Cancer Ther.
14:1192–1201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu F, Tan G, Li J, Dong X, Krissansen GW
and Sun X: Gene transfer of endostatin enhances the efficacy of
doxorubicin to suppress human hepatocellular carcinomas in mice.
Cancer Sci. 98:1381–1387. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin K, Ye P, Liu J, He F and Xu W:
Endostar inhibits hypoxia-induced cell proliferation and migration
via the hypoxia-inducible factor-1α/vascular endothelial growth
factor pathway in vitro. Mol Med Rep. 11:3780–3785. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li N, Zheng D, Wei X, Jin Z, Zhang C and
Li K: Effects of recombinant human endostatin and its synergy with
cisplatin on circulating endothelial cells and tumor vascular
normalization in A549 xenograft murine model. J Cancer Res Clin
Oncol. 138:1131–1144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang G and Chen L: Recombinant human
endostatin improves anti-tumor efficacy of paclitaxel by
normalizing tumor vasculature in Lewis lung carcinoma. J Cancer Res
Clin Oncol. 136:1201–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao W, Zhang L, Yin Z, Su W, Ren G, Zhou
C, You J, Fan J and Wang X: Activated hepatic stellate cells
promote hepatocellular carcinoma development in immunocompetent
mice. Int J Cancer. 129:2651–2661. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Khan MA, Assiri AM and Broering DC:
Complement and macrophage crosstalk during process of angiogenesis
in tumor progression. J Biomed Sci. 22:582015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gomes FG, Nedel F, Alves AM, Nör JE and
Tarquinio SB: Tumor angiogenesis and lymphangiogenesis:
Tumor/endothelial crosstalk and cellular/microenvironmental
signaling mechanisms. Life Sci. 92:101–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tassi E and Wellstein A: Tumor
angiogenesis: Initiation and targeting-therapeutic targeting of an
FGF-binding protein, an angiogenic switch molecule, and indicator
of early stages of gastrointestinal adenocarcinomas. Cancer Res
Treat. 38:189–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cutolo M, Montagna P, Soldano S, Contini
P, Paolino S, Pizzorni C, Seriolo B, Sulli A and Brizzolara R:
CTLA4-Ig/CD86 interactions in cultured human endothelial cells:
Effects on VEGFR-2 and ICAM1 expression. Clin Exp Rheumatol.
33:250–254. 2015.PubMed/NCBI
|
|
21
|
Fagiani E, Bill R, Pisarsky L, Ivanek R,
Rüegg C and Christofori G: An immature B cell population from
peripheral blood serves as surrogate marker for monitoring tumor
angiogenesis and anti-angiogenic therapy in mouse models.
Angiogenesis. 18:327–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao SR, Li LM, Xia HP, Wang GM, Xu HY and
Wang AR: Clinical observation on recombinant human endostatin
combined with chemotherapy for advanced gastrointestinal cancer.
Asian Pac J Cancer Prev. 16:4037–4040. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Persad R, Liu C, Wu TT, Houlihan PS,
Hamilton SR, Diehl AM and Rashid A: Overexpression of caspase-3 in
hepatocellular carcinomas. Mod Pathol. 17:861–867. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Wang S, Feng L, Ma D, Fu Q, Song Y,
Jia X and Ma S: Hypoglycemic and antioxidant activities of paeonol
and its beneficial effect on diabetic encephalopathy in
streptozotocin-induced diabetic rats. J Med Food. 16:577–586. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Territo PR, Maluccio M, Riley AA, McCarthy
BP, Fletcher J, Tann M, Saxena R and Skill NJ: Evaluation of
11C-acetate and 18 F-FDG PET/CT in mouse multidrug resistance
gene-2 deficient mouse model of hepatocellular carcinoma. BMC Med
Imaging. 15:152015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fujii T, Nomoto S, Koshikawa K, Yatabe Y,
Teshigawara O, Mori T, Inoue S, Takeda S and Nakao A:
Overexpression of pituitary tumor transforming gene 1 in HCC is
associated with angiogenesis and poor prognosis. Hepatology.
43:1267–1275. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roderburg C, Gautheron J and Luedde T:
TNF-dependent signaling pathways in liver cancer: Promising targets
for therapeutic strategies? Dig Dis. 30:500–507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dhanasekaran R, Limaye A and Cabrera R:
Hepatocellular carcinoma: Current trends in worldwide epidemiology,
risk factors, diagnosis, and therapeutics. Hepat Med. 4:19–37.
2012.PubMed/NCBI
|
|
30
|
Zhu JY, Sun QK, Wang W and Jia WD:
High-level expression of HOXB13 is closely associated with tumor
angiogenesis and poor prognosis of hepatocellular carcinoma. Int J
Clin Exp Pathol. 7:2925–2933. 2014.PubMed/NCBI
|
|
31
|
Ye Q, Qin S, Liu Y, Feng J, Wu Q, Qu W and
Yin X: Inhibitory effect of Endostar on specific angiogenesis
induced by human hepatocellular carcinoma. Gastroenterol Res Pract.
2015:9575742015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Buachan P, Chularojmontri L and
Wattanapitayakul SK: Selected activities of Citrus maxima Merr.
Fruits on human endothelial cells: Enhancing cell migration and
delaying cellular aging. Nutrients. 6:1618–1634. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Feng G, Lei Z, Wang D, Xu N, Wei Q, Li D
and Liu J: The evaluation of anti-angiogenic effects of Endostar on
rabbit VX2 portal vein tumor thrombus using perfusion MSCT. Cancer
Imaging. 14:172014.PubMed/NCBI
|
|
34
|
Bialecki ES and Di Bisceglie AM: Diagnosis
of hepatocellular carcinoma. HPB (Oxford). 7:26–34. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bayati N, Silverman AL and Gordon SC:
Serum alpha-fetoprotein levels and liver histology in patients with
chronic hepatitis C. Am J Gastroenterol. 93:2452–2456. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Riaz A, Ryu RK, Kulik LM, Mulcahy MF,
Lewandowski RJ, Minocha J, Ibrahim SM, Sato KT, Baker T, Miller FH,
et al: Alpha-fetoprotein response after locoregional therapy for
hepatocellular carcinoma: Oncologic marker of radiologic response,
progression, and survival. J Clin Oncol. 27:5734–5742. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Skill NJ, Jianmin W, Yan X, Zhao Z, Tector
AJ and Maluccio MA: Lysophospholipid variants in hepatocellular
carcinoma. J Surg Res. 182:241–249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rancoule C, Pradère JP, Gonzalez J, Klein
J, Valet P, Bascands JL, Schanstra JP and Saulnier-Blache JS:
Lysophosphatidic acid-1-receptor targeting agents for fibrosis.
Expert Opin Investig Drugs. 20:657–667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jongsma M, Matas-Rico E, Rzadkowski A,
Jalink K and Moolenaar WH: LPA Is a chemorepellent for B16 melanoma
cells: Action through the cAMP-Elevating LPA5 receptor. PLoS One.
6:e292602011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao C, Sardella A, Chun J, Poubelle PE,
Fernandes MJ and Bourgoin SG: TNF-alpha promotes LPA1-and
LPA3-mediated recruitment of leukocytes in vivo through CXCR2
ligand chemokines. J Lipid Res. 52:1307–1318. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Betof AS, Lascola CD, Weitzel D, Landon C,
Scarbrough PM, Devi GR, Palmer G, Jones LW and Dewhirst MW:
Modulation of murine breast tumor vascularity, hypoxia and
chemotherapeutic response by exercise. J Natl Cancer Inst. 107:pii:
djv0402015. View Article : Google Scholar
|
|
42
|
Zhang J, Liu Q, Hu X, Fang Z, Huang F,
Tang L and Zhou S: Apelin/APJ signaling promotes hypoxia-induced
proliferation of endothelial progenitor cells via
phosphoinositide-3 kinase/Akt signaling. Mol Med Rep. 12:3829–3834.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang J and Hao J: Role of HIF-1α in
hypoxic microenvironment of tumor and the targeted therapy. Chin J
Clin Oncol. 1–1075. 2013. View Article : Google Scholar
|
|
44
|
Monteiro LS, Delgado ML, Ricardo S, Garcez
F, do Amaral B, Pacheco JJ, Lopes C and Bousbaa H: EMMPRIN
expression in oral squamous cell carcinomas: Correlation with tumor
proliferation and patient survival. Biomed Res Int.
2014:9056802014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kowshik J, Mishra R, Sophia J, Rautray S,
Anbarasu K, Reddy GD, Dixit M, Mahalingam S and Nagini S: Nimbolide
upregulates RECK by targeting miR-21 and HIF-1α in cell lines and
in a hamster oral carcinogenesis model. Sci Rep. 7:20452017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Huang H, Song Y, Wu Y, Guo N, Ma Y and
Qian L: Erbin loss promotes cancer cell proliferation through
feedback activation of Akt-Skp2-p27 signaling. Biochem Biophys Res
Commun. 463:370–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kazemi-Lomedasht F, Behdani M, Pooshang
Bagheri K, Habibi Anbouhi M, Abolhassani M, Khanahmad H,
Shahbazzadeh D and Mirzahoseini H: Expression and purification of
functional human vascular endothelial growth factor-A121; the most
important angiogenesis factor. Adv Pharm Bull. 4:323–328.
2014.PubMed/NCBI
|
|
48
|
Huang TH, Chiu YH, Chan YL, Chiu YH, Wang
H, Huang KC, Li TL, Hsu KH and Wu CJ: Prophylactic administration
of fucoidan represses cancer metastasis by inhibiting vascular
endothelial growth factor (VEGF) and matrix metalloproteinases
(MMPs) in Lewis tumor-bearing mice. Mar Drugs. 13:1882–1900. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lopez-Avila V and Spencer J: Methods for
detection of matrix metalloproteinases as biomarkers in
cardiovascular disease. Clin Med Insights Cardiol. 2:75–87.
2008.
|
|
50
|
Alexius-Lindgren M, Andersson E, Lindstedt
I and Engström W: The RECK gene and biological malignancy-its
significance in angiogenesis and inhibition of matrix
metalloproteinases. Anticancer Res. 34:3867–3873. 2014.PubMed/NCBI
|
|
51
|
Emingil G, Tervahartiala T, Mãntylã P,
Määttä M, Sorsa T and Atilla G: Gingival crevicular fluid matrix
metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue
inhibitor of MMP-1 levels in periodontal disease. J Periodontol.
77:2040–2050. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Monteiro-Amado F, Castro-Silva II, Lima
CJ, Soares FA, Kowalski LP and Granjeiro JM: Immunohistochemical
evaluation of MMP-2, MMP-9 and CD31/microvascular density in
squamous cell carcinomas of the floor of the mouth. Braz Dent J.
24:3–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Griffioen AW: Anti-angiogenesis: Making
the tumor vulnerable to the immune system. Cancer Immunol
Immunother. 57:1553–1558. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sabnani MK, Rajan R, Rowland B, Mavinkurve
V, Wood LM, Gabizon AA and La-Beck NM: Liposome promotion of tumor
growth is associated with angiogenesis and inhibition of antitumor
immune responses. Nanomedicine. 11:259–262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mu X, Sang Y, Fang C, Shao B, Yang L, Yao
K, Zhao X, Gou J, Wei Y, Yi T, et al: Immunotherapy of tumors with
human telomerase reverse transcriptase immortalized human umbilical
vein endothelial cells. Int J Oncol. 47:1901–1911. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhu J, Wang Y, Yang F, Sang L, Zhai J, Li
S, Li Y, Wang D, Lu C and Sun X: IL-33 alleviates DSS-induced
chronic colitis in C57BL/6 mice colon lamina propria by suppressing
Th17 cell response as well as Th1 cell response. Int
Immunopharmacol. 29:846–853. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gagliani N, Amezcua Vesely MC, Iseppon A,
Brockmann L, Xu H, Palm NW, de Zoete MR, Licona-Limón P, Paiva RS,
Ching T, et al: Th17 cells transdifferentiate into regulatory T
cells during resolution of inflammation. Nature. 523:221–225. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang H, Zhang L, Zhang S and Li Y:
Inhibition of vascular endothelial growth factor by small
interfering RNA upregulates differentiation, maturation and
function of dendritic cells. Exp Ther Med. 9:120–124. 2015.
View Article : Google Scholar : PubMed/NCBI
|
